Real-world experience of rIX-FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy - Results from IDEAL Part B.

Subjects

Subjects :

Humans
Italy epidemiology
Adult
Male
Factor IX therapeutic use
Factor IX administration & dosage
Middle Aged
Young Adult
Female
Adolescent
Drug Administration Schedule
Aged
Hemophilia B drug therapy

Details

Language :

English

ISSN :

1365-2516

Volume :

30

Issue :

4

Database :

MEDLINE

Journal :

Haemophilia : the official journal of the World Federation of Hemophilia

Publication Type :

Editorial & Opinion

Accession number :

39014893

Full Text :

https://doi.org/10.1111/hae.15074